Loading

Advanced Business Development-Day 2 of 3

June 14, 2025
Course - Additional Fee
210B

This is a three day course requiring attendance on all three days.

"Advanced Business Development "(ABD) is a long-running course focusing on all key aspects of transactions in the biopharma industry. This course is ideal for professionals ranging from those with limited experience (2–3 years) looking to advance their skills; and highly experienced dealmakers or executives looking to hone their skills and network with other dealmakers.

"Advanced Business Development"incorporates lectures from experienced dealmakers, review of example models, dissection of actual deals, interaction with other participants, and live Q&A. Also, the course includes a mock negotiation scenario when each participant is a member of a deal team assigned to negotiate a transaction involving a drug in development with another team using an actual valuation and deal structuring model.

Takeaways:
  • Business development practices
  • Trends in BD transactions
  • Valuation, analytics, and models
  • Deal structuring
  • Negotiation -Intellectual property
  • Legal terms, term sheets, and agreements
  • Due diligence
  • Live, interactive case study work

Course Price:
BIO Member: $2,550
Non-Member: $3,190 

Faculty
Joseph Dillon
Joseph Dillon, PhD, MBA
President & CEO
SynerPhysics
Patrick Duxbury
Patrick Duxbury, JD
Of Counsel, Leader of Life Sciences (UK)
Gowling WLG
Sharmela Kalmer
Sharmela Kalmer, LLB, LLM
Partner
Gowling WLG
Kenneth Krisko
Kenneth Krisko, JD
Partner
Cooley, LLP
Stephanie Palmer
Stephanie Palmer, JD
Special Counsel
Cooley LLP
Lesley Stolz
Lesley Stolz, PhD
Head West North America External Scientific Innovation
Johnson & Johnson
Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS